PaxMedia hires ShareIntel to look into recent stock weakness, after a 45% plunge amid an 8-day losing streakMarket Watch • 06/22/23
PaxMedica Enters Research Collaboration Agreement With PoloMar Health for Phase II Study in Autism Spectrum DisorderGlobeNewsWire • 06/08/23
PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023GlobeNewsWire • 05/15/23
PaxMedica Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering and Autism Awareness MonthGlobeNewsWire • 04/19/23
PaxMedica, Inc. Provides Business Update and Reports Fourth Quarter 2022 Financial ResultsGlobeNewsWire • 03/29/23
PaxMedica to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor ConferenceGlobeNewsWire • 11/22/22